
Therapeutic Targeting in Ovarian Cancer: Nano-Enhanced CRISPR/Cas9 Gene Editing and Drug Combination Therapy
Introduction Ovarian cancer is a malignant tumor that originates in the ovary and can arise from the surface of ovary, the fallopian tubes, or the mesothelium-lined peritoneal cavity.1 Ovarian cancer is the third most common gynecologic malignancy, …